Jasmine Zain

Also affiliated with Memorial Sloan Kettering Cancer Center, City of Hope

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies”.

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3706

N/A

4.4DataRank · unranked

198 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Blood(2022)10.1182/blood.2022015423

N/A

3.0DataRank · unranked

121 citations

Hun Ju Lee, Joycelynne Palmer, Robert Chen, Ni‐Chun Tsai, Lu Chen +18 more

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study

The Lancet Haematology(2021)10.1016/s2352-3026(21)00103-4

N/A

2.5DataRank · unranked

86 citations

Graham P. Collins, Paolo F. Caimi, Felipe Samaniego, Alexander I. Spira, Andrew Davies +13 more

Safety and efficacy of navitoclax, a BCL-2 and BCL-X L inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1845332

N/A

2.2DataRank · unranked

94 citations

John P. Leonard, Jonathan W. Friedberg, Jasmine Zain, Kieron Dunleavy, Rod Humerickhouse +4 more

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Blood(2023)10.1182/blood.2023020485

N/A

1.3DataRank · unranked

40 citations

Lu Chen, James Godfrey, Joo Y. Song, Colt A. Egelston, Sandrine Puverel +18 more

Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study

The Lancet Haematology(2024)10.1016/s2352-3026(24)00171-6

N/A

0.673DataRank · unranked

20 citations

Jasmine Zain, Kerry J. Savage, Tatyana Feldman, Jonathan E. Brammer, Lu Chen +14 more

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Blood(2023)10.1182/blood.2023020244

N/A

0.598DataRank · unranked

15 citations

Parastoo B. Dahi, Robert Redd, Mikaela M. McDonough, Yi‐Bin Chen, Zachariah DeFilipp +15 more

The impact of gender, age, race/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas

Supportive Care in Cancer(2021)10.1007/s00520-021-06241-6

N/A

0.385DataRank · unranked

12 citations

Arnab Chowdhury, Tracey Stiller, Joycelynne Palmer, Matthew Loscalzo, Estella Barrios +5 more

Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort study

British Journal of Dermatology(2024)10.1093/bjd/ljae039

N/A

0.292DataRank · unranked

6 citations

Lu Chen, Jasmine Zain, Steven T. Rosen, Christiane Querfeld, Nicholas A. Trum

TMLI and Skin Irradiation as Conditioning Regimens for Allogeneic Hematopoietic Cell Transplant in T-Cell Lymphoma Patients

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3135

N/A

0DataRank · unranked

0 citations

Anxiang Wen, Claire Hao, Colton Ladbury, Paul Frankel, Oluwatimilehin Okunowo +15 more

Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2378

N/A

0DataRank · unranked

43 citations

Anamarija M. Perry, Alex F. Herrera, Lu Chen, Pamela Skrabek, Michel R. Nasr +19 more

Emerging drugs for the treatment of cutaneous T-cell lymphoma

Expert Opinion on Emerging Drugs(2022)10.1080/14728214.2022.2049233

N/A

0DataRank · unranked

23 citations

Jasmine Zain, Steven T. Rosen, Christiane Querfeld, Melissa Cheng

Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2022.7100

N/A

0DataRank · unranked

12 citations

Aleksi Iukuridze, Tianhui He, Alysia Bosworth, Lanie Lindenfeld, Jennifer Berano Teh +17 more

Data from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

(2023)10.1158/1078-0432.c.6531017.v1

N/A

0DataRank · unranked

0 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

Data from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

(2023)10.1158/1078-0432.c.6531017

N/A

0DataRank · unranked

0 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

383 | NEXT‐GENERATION SEQUENCING REVEALS T CELL RECEPTOR BETA AND GAMMA CLONOTYPES ASSOCIATED WITH AGGRESSIVE SUBTYPES OF MYCOSIS FUNGOIDES/SEZARY SYNDROME AND POOR PROGNOSIS

Hematological Oncology(2025)10.1002/hon.70094_383

N/A

0DataRank · unranked

0 citations

Liliana Crisan, J. Li, Raju Pillai, Jasmine Zain, S. T. Rosen +2 more

399 | DURVALUMAB AND LENALIDOMIDE SHOWS SUPERIOR EFFICACY OVER SINGLE‐AGENT DURVALUMAB IN REFRACTORY/ADVANCED CUTANEOUS T CELL LYMPHOMA: RESULTS FROM A RANDOMIZED PHASE 2 TRIAL

Hematological Oncology(2025)10.1002/hon.70094_399

N/A

0DataRank · unranked

0 citations

L. CHEN, Xiwei Wu, Zhen Han, Chingyu Su, Yate‐Ching Yuan +7 more

120 | DETECTION OF INTRATUMORAL MICROORGANISMS AND THEIR IMPACT ON OUTCOMES IN UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA

Hematological Oncology(2025)10.1002/hon.70093_120

N/A

0DataRank · unranked

0 citations

Chad Vanderbilt, Teng Fei, Ticiane Henriques Santa Rita, A. Rivas Delgado, Annie Qiu +31 more